Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
RCT
ACE Report #11551
Ace Report Cover Spine

IV and topical TXA superior to placebo for hematological outcomes after PLIF


Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Intravenous Administration of Tranexamic Acid Significantly Reduces Visible and Hidden Blood Loss Compared with Its Topical Administration for Double-Segment Posterior Lumbar Interbody Fusion: A Single-Center, Placebo-Controlled, Randomized Trial

World Neurosurg. 2019 Feb;122:e821-e827.

Contributing Authors: J Wei Z Li C Wang X Mu Y Ou D Yin B Liang D Qiu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

150 patients with lumbar degenerative disease and scheduled for a posterior lumbar interbody fusion procedure were randomized to receive intravenous TXA, topical TXA or placebo for blood loss. Outcomes of interest included hemoglobin, hematocrit and fibrinogen levels, prothrombin time, extubation time, hospital length of stay, post-operative Visual Analog Scale (VAS), intra-operative blood loss, d...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.